140 related articles for article (PubMed ID: 2643726)
1. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma.
Nemoto R; Uchida K; Shimazui T; Hattori K; Koiso K; Harada M
J Urol; 1989 Feb; 141(2):337-40. PubMed ID: 2643726
[TBL] [Abstract][Full Text] [Related]
2. S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling.
Nemoto R; Hattori K; Uchida K; Shimazui T; Nishijima Y; Koiso K; Harada M
Cancer; 1990 Aug; 66(3):509-14. PubMed ID: 2194646
[TBL] [Abstract][Full Text] [Related]
3. S phase fraction of human bladder tumor measured in situ with bromodeoxyuridine labeling.
Nemoto R; Uchida K; Hattori K; Shimazui T; Nishijima Y; Saito S; Koiso K; Harada M
J Urol; 1988 Feb; 139(2):286-9. PubMed ID: 3276925
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
Nagashima T; DeArmond SJ; Murovic J; Hoshino T
Acta Neuropathol; 1985; 67(1-2):155-9. PubMed ID: 2992212
[TBL] [Abstract][Full Text] [Related]
6. Estimations of the S phase fraction in situ in transitional cell carcinoma of the renal pelvis and ureter with bromodeoxyuridine labelling.
Nemoto R; Hattori K; Sasaki A; Miyanaga N; Koiso K; Harada M
Br J Urol; 1989 Oct; 64(4):339-44. PubMed ID: 2819383
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA)/cyclin in human prostate adenocarcinoma.
Nemoto R; Kawamura H; Miyakawa I; Uchida K; Hattori K; Koiso K; Harada M
J Urol; 1993 Jan; 149(1):165-9. PubMed ID: 8093265
[TBL] [Abstract][Full Text] [Related]
8. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Davis RL
Cancer; 1986 Oct; 58(7):1466-72. PubMed ID: 2427189
[TBL] [Abstract][Full Text] [Related]
9. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
10. Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody.
Nishizaki T; Orita T; Saiki M; Furutani Y; Aoki H
J Neurosurg; 1988 Sep; 69(3):371-4. PubMed ID: 3404235
[TBL] [Abstract][Full Text] [Related]
11. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical demonstration of S-phase cells in bladder tumors by anti-bromodeoxyuridine monoclonal antibody. Using in vitro labeling method].
Tsujihashi H; Matsuda H; Akiyama T; Kurita T; Uejima S
Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):423-7. PubMed ID: 3221593
[No Abstract] [Full Text] [Related]
13. Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.
Nagashima T; Hoshino T; Cho KG; Senegor M; Waldman F; Nomura K
J Neurosurg; 1988 Mar; 68(3):388-92. PubMed ID: 3278075
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.
Nagashima T; Hoshino T
Acta Neuropathol; 1985; 66(1):12-7. PubMed ID: 3993331
[TBL] [Abstract][Full Text] [Related]
15. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Risio M; Coverlizza S; Poccardi G; Candelaresi GL; Gaiola O
Basic Appl Histochem; 1986; 30(4):469-77. PubMed ID: 3548696
[TBL] [Abstract][Full Text] [Related]
16. Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine.
Magaud JP; Sargent I; Clarke PJ; Ffrench M; Rimokh R; Mason DY
J Histochem Cytochem; 1989 Oct; 37(10):1517-27. PubMed ID: 2476478
[TBL] [Abstract][Full Text] [Related]
17. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Lee SS; Lee TS; Park JS; Cho EK; Chung CH
J Korean Med Sci; 1989 Dec; 4(4):193-201. PubMed ID: 2639694
[TBL] [Abstract][Full Text] [Related]
18. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of monoclonal antibody against gamma-seminoprotein in the prostatic tissues. A significant correlation between the degree of staining and the histological grade of adenocarcinoma of the prostate].
Fujino A; Ishida H; Ohhori M; Soh S; Nishimura K; Endo T; Koshiba K; Kuwao S
Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):720-8. PubMed ID: 7684101
[TBL] [Abstract][Full Text] [Related]
20. Estimation of growth fraction in situ in human bladder cancer with bromodeoxyuridine labelling.
Nemoto R; Hattori K; Uchida K; Shimazui T; Koiso K; Harada M
Br J Urol; 1990 Jan; 65(1):27-31. PubMed ID: 2310929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
